Skip to main content
. 2021 Feb 26;110(5):740–753. doi: 10.1007/s00392-021-01814-1

Table 2.

Safety and performance parameters

Assessment Purpose Follow-up timepoints Evaluator
Angiography To assess vessel patency Baseline, procedure, and sacrifice (90 days) Independent board-certified radiologist
Animal health To assess animal health for any clinically significant observations Monitored throughout the study duration through sacrifice (90 days) Independent board-certified veterinarian
Clinical pathology (bloodwork)

To assess hematology and serum chemistry values related to animal health, including:

• Liver

• Pancreas

• Kidney function

Pre-treatment, intermediate time point (30 days) and at sacrifice (90 days) Independent board-certified veterinarian
Gross pathology (necropsy)

To assess any gross abnormalities, including:

• Hepatic parenchyma of all liver lobes

• Head, body, and tail of the pancreas

• Proximal duodenum

• Gall bladder

• Kidneys

• Small bowel

• Psoas muscle adjacent to the renal arteries

At sacrifice (90 days) Independent board-certified veterinary pathologist
Histopathology of the treatment area (renal arteries, common hepatic artery and surrounding tissues)

To assess:

• Morphologic characterization of treatment area, including depth and circumferentiality

• Vessel wall injury

• Perivascular injury

At sacrifice (90 days) Independent board-certified veterinary pathologist
Norepinephrine assessment To assess denervation of the liver, kidneys and adjacent organs (pancreas and duodenum) At sacrifice (90 days) Independent test laboratory